ArticleBreast cancer research and treatment2020
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
Inge-Marie Obdeijn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it